These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 8566099

  • 1. Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.
    Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S.
    Eur J Pharmacol; 1995 Jul 14; 280(3):311-6. PubMed ID: 8566099
    [Abstract] [Full Text] [Related]

  • 2. Different contributions of the endothelin ET(A) receptor to hypertension induced by acute or chronic inhibition of nitric oxide synthesis.
    Hashimoto N, Kuro T, Taira S, Matsumura Y.
    J Pharm Pharmacol; 1998 Sep 14; 50(9):1051-8. PubMed ID: 9811167
    [Abstract] [Full Text] [Related]

  • 3. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Takaoka M, Morimoto S.
    Jpn J Pharmacol; 1996 Apr 14; 70(4):313-9. PubMed ID: 8774759
    [Abstract] [Full Text] [Related]

  • 4. Ameliorating effect of an endothelin ETA receptor antagonist on renal function of DOCA-salt hypertensive rats.
    Matsumura Y, Hashimoto N, Fujita K, Morimoto S.
    Eur J Pharmacol; 1997 Jan 14; 319(1):65-9. PubMed ID: 9030899
    [Abstract] [Full Text] [Related]

  • 5. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
    Fujita K, Matsumura Y, Miyazaki Y, Hashimoto N, Takaoka M, Morimoto S.
    Life Sci; 1996 Jan 14; 58(1):PL1-7. PubMed ID: 8628104
    [Abstract] [Full Text] [Related]

  • 6. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
    Fujita K, Matsumura Y, Kita S, Miyazaki Y, Hisaki K, Takaoka M, Morimoto S.
    Br J Pharmacol; 1995 Mar 14; 114(5):925-30. PubMed ID: 7780646
    [Abstract] [Full Text] [Related]

  • 7. Effects of FR139317 on renal responses to acute nitric oxide blockade in anaesthetized rats.
    Matsumura Y, Kuro T, Hashimoto N, Taira S.
    Clin Exp Pharmacol Physiol; 1998 Jun 14; 25(6):441-4. PubMed ID: 9673820
    [Abstract] [Full Text] [Related]

  • 8. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
    Matsumura Y, Fujita K, Miyazaki Y, Takaoka M, Morimoto S.
    J Cardiovasc Pharmacol; 1995 Jun 14; 26 Suppl 3():S456-8. PubMed ID: 8587444
    [Abstract] [Full Text] [Related]

  • 9. Renal effects of endothelin in anesthetized rabbits.
    Ono N, Matsui T, Yoshida M, Suzuki-Kusaba M, Hisa H, Satoh S.
    Eur J Pharmacol; 1998 Oct 23; 359(2-3):177-84. PubMed ID: 9832389
    [Abstract] [Full Text] [Related]

  • 10. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
    Sventek P, Li JS, Grove K, Deschepper CF, Schiffrin EL.
    Hypertension; 1996 Jan 23; 27(1):49-55. PubMed ID: 8591887
    [Abstract] [Full Text] [Related]

  • 11. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
    Banting JD, Friberg P, Adams MA.
    J Hypertens; 1996 Aug 23; 14(8):975-81. PubMed ID: 8884552
    [Abstract] [Full Text] [Related]

  • 12. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
    Matsuura T, Miura K, Ebara T, Yukimura T, Yamanaka S, Kim S, Iwao H.
    Br J Pharmacol; 1997 Sep 23; 122(1):81-6. PubMed ID: 9298531
    [Abstract] [Full Text] [Related]

  • 13. Endothelin and gelatinases in renal changes following blockade of nitric oxide synthase in hypertensive rats.
    Yang YL, Liu DD, Hsieh NK, Chen HI.
    Chin J Physiol; 2008 Jun 30; 51(3):186-95. PubMed ID: 18935914
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the role of endothelin-A and endothelin-B receptors on nociceptive information transmission in the spinal cord with FR139317, an endothelin-A receptor antagonist, and sarafotoxin S6c, an endothelin-B receptor agonist.
    Yamamoto T, Shimoyama N, Asano H, Mizuguchi T.
    J Pharmacol Exp Ther; 1994 Oct 30; 271(1):156-63. PubMed ID: 7965709
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endothelin and blood pressure regulation in the female rat: studies in normal pregnancy and with nitric oxide synthase inhibition-induced hypertension.
    Thaete LG, Neerhof MG.
    Hypertens Pregnancy; 2000 Oct 30; 19(2):233-47. PubMed ID: 10877991
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
    Li JS, Sventek P, Schiffrin EL.
    J Hypertens; 1996 Nov 30; 14(11):1331-9. PubMed ID: 8934362
    [Abstract] [Full Text] [Related]

  • 20. Effect of combination of a tissue-type plasminogen activator and an endothelin receptor antagonist, FR139317, in the rat cerebral infarction model.
    Umemura K, Ishiye M, Kosuge K, Nakashima M.
    Eur J Pharmacol; 1995 Feb 24; 275(1):17-21. PubMed ID: 7774658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.